BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12182985)

  • 21. Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma.
    Guarneri A; Franco P; Romagnoli R; Trino E; Mirabella S; Molinaro L; Rizza G; Filippi AR; Carucci P; Salizzoni M; Ricardi U
    Radiol Med; 2016 Nov; 121(11):873-881. PubMed ID: 27447803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
    Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
    J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.
    Strigari L; Sciuto R; Rea S; Carpanese L; Pizzi G; Soriani A; Iaccarino G; Benassi M; Ettorre GM; Maini CL
    J Nucl Med; 2010 Sep; 51(9):1377-85. PubMed ID: 20720056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma.
    Choi C; Koom WS; Kim TH; Yoon SM; Kim JH; Lee HS; Nam TK; Seong J
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1051-60. PubMed ID: 25303890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization.
    Liu MT; Li SH; Chu TC; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Lin JP
    Jpn J Clin Oncol; 2004 Sep; 34(9):532-9. PubMed ID: 15466827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
    Rosenzweig KE; Mychalczak B; Fuks Z; Hanley J; Burman C; Ling CC; Armstrong J; Ginsberg R; Kris MG; Raben A; Leibel S
    Cancer J; 2000; 6(2):82-7. PubMed ID: 11069224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
    Hata M; Tokuuye K; Sugahara S; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Akine Y
    Strahlenther Onkol; 2006 Dec; 182(12):713-20. PubMed ID: 17149578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single photon emission computed tomography-based three-dimensional conformal radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus.
    Shirai S; Sato M; Suwa K; Kishi K; Shimono C; Kawai N; Tanihata H; Minamiguchi H; Nakai M
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):824-31. PubMed ID: 18755560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.
    Lau WY; Ho S; Leung TW; Chan M; Ho R; Johnson PJ; Li AK
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):583-92. PubMed ID: 9486608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation treatment outcomes for unresectable hepatocellular carcinoma.
    Skinner HD; Sharp HJ; Kaseb AO; Javle MM; Vauthey JN; Abdalla EK; Delclos ME; Das P; Crane CH; Krishnan S
    Acta Oncol; 2011 Nov; 50(8):1191-8. PubMed ID: 21793641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization.
    Seong J; Park HC; Han KH; Lee DY; Lee JT; Chon CY; Moon YM; Suh CO
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1331-5. PubMed ID: 10889387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH; Chen LH
    Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.
    Robertson JM; McGinn CJ; Walker S; Marx MV; Kessler ML; Ensminger WD; Lawrence TS
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1087-92. PubMed ID: 9392548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma.
    Shiba S; Abe T; Shibuya K; Katoh H; Koyama Y; Shimada H; Kakizaki S; Shirabe K; Kuwano H; Ohno T; Nakano T
    BMC Cancer; 2017 Nov; 17(1):721. PubMed ID: 29115938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
    Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
    Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
    J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma.
    Jung J; Yoon SM; Cho B; Choi YE; Kwak J; Kim SY; Lee SW; Ahn SD; Choi EK; Kim JH
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):96-101. PubMed ID: 26503671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early three-dimensional conformal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: a prospective evaluation of efficacy and toxicity.
    Oh D; Lim DH; Park HC; Paik SW; Koh KC; Lee JH; Choi MS; Yoo BC; Lim HK; Lee WJ; Rhim H; Shin SW; Park KB
    Am J Clin Oncol; 2010 Aug; 33(4):370-5. PubMed ID: 20142728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.